Page last updated: 2024-10-26

dipyridamole and Ambulation Disorders, Neurologic

dipyridamole has been researched along with Ambulation Disorders, Neurologic in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"The dorso-lateral medullary syndrome (Wallenberg's syndrome) is produced by infarction of a wedge of lateral medulla posterior to the inferior olivary nucleus and is usually caused by vertebral artery occlusion."1.33The clinical variability of Wallenberg's syndrome. The anatomical correlate of ipsilateral axial lateropulsion. ( Nowak, DA; Topka, HR, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nowak, DA1
Topka, HR1

Other Studies

1 other study available for dipyridamole and Ambulation Disorders, Neurologic

ArticleYear
The clinical variability of Wallenberg's syndrome. The anatomical correlate of ipsilateral axial lateropulsion.
    Journal of neurology, 2006, Volume: 253, Issue:4

    Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain; Cerebral Infarction; Clopidogrel; Dipyridam

2006